High concentration baclofen preparations

Details High concentration baclofen preparations High concentration baclofen preparations

2010-09-28

2011-11-22

Padmanabhan, Sreeni (Department: 1627)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

C514S567000

Reexamination Certificate

active

08062647

ABSTRACT:
Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.

REFERENCES:
patent: 5149713 (1992-09-01), Bousquet
patent: 2004/0062819 (2004-04-01), Hildebrand
Moberg-Wolff, Potential Clinical Impact of Compounded Versus Noncompounded Intrathecal Baclofen, Nov. 2009, Archives of Physical Medicine and Rehabilitation, vol. 90, Issue 11, 1815-1820.
Sigg et al., Solubility and Stability of Intrathecal Baclofen Solutions at High Concentrations: Implications for Chronic Use in the SynchroMed® Infusion System, White Paper 2007, Minneapolis: Medtronic Neurological, 2007, reprinted from http://www.tamethepain.com/wcm/groups/mdtcom—sg/@mdt/@neuro/documents/documents/itb-solubility-wp.pdf, 13 pages.
Baum, S. and Schuster, F., “Production and Testing of Baclofen Solutions,” Pharmazeutische Zeitung, vol. 133, Germany, pp. 28-32 (1988).
Diogenes Record No. 2905396, MDR Report: Neurological Division, Medtronic, Inc. Indura LKK, Model #8731 (2008).
Diogenes Record No. 2779300, MDR Report: Medtronic, Inc. Synchromed B Pump, Intrathecal, Model #8267 (2007).
Diogenes Record No. 2596683, MDR Report: Rice Creek Manufacturing Indura Catheter, Model #8709 (2006).
Ridley, B. and Rawlins, P., “Intrathecal Baclofen Therapy: Ten Steps Toward Best Practice,” Journal of Neuroscience Nursing: 38:2, pp. 72-82 (2006).
International Search Report dated Sep. 5, 2005.
Ahuja S., “Baclofen,”Analytical Profiles of Drug Substances, vol. 14, New York: Academic Press, pp. 527-548, 1985.
Allen L. V., et al., “Stability of Baclofen, Captopril, Diltiazem Hydrochloride, Dipyridamole, and Flecainide Acetate is Extemporaneously Compounded Oral Liquids”,Am J Health-Syst. Pharm., 53:2179-2184, 1996.
Cruaud et al., “The Characterization and Release Kinetics Evaluation of Baclofen Microspheres Designed for Intrathecal Injection”,Int. J. Pharmacuetics, 177, 247-257), 1999.
Gupta V. D., Parasrampuria J., “Quantitation of 4-(4-chlorophenyl)-2-pyrrolidine in baclofen powder and tablets,”Drug Develop. Indust. Pharm., 14: 1623-1628, 1998.
Holloway, R. H., “Systemic Pharmacomodulation of Transient Lower Esophageal Sphincter Relations,”Amer. J. Medicine, 111:8A, 178S-185S, 2001.
Johnson C. E., et al., “Stablility of an extemporaneously compounded baclofen oral liquid”,Am. J. Hosp. Pharm., 50:2353-55, 1993.
Lioresal Intrathecal package insert, Medtronic Neurological, Minneapolis, Minnesota, Apr. 1997.
McEvoy G.,AHFS Drug Information 2004, Bethesda, MD: American Society of Health-System Pharmacists, 2004.
Sitaram B.R., Tsui M., Rawicki H. B., et al., “Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine”,Int. J. Pharm., 153: 13-24, 1997.
United States Pharmacopeia 27thed., Rockville, MD: United States Pharmacopeial Convention, 2004.
USP Dictionary of USAN and International Drug Names 2003, Rockville, MD: United States Pharmacopeial Convention, 2003.
Cardiff, L and Rieck, A.M., “Concentrating on Baclofen,” Australian Journal of Hospital Pharmacy, Feb. 1995, vol. 25, No. 1, pp. 102-103 (abstract).
Considered Analysis of the Use of Prostaglandin E2 Gel for the Induction of Labour, Concentrating on Baclofen, Creating a Pharmacist Out of Thin Air? Using Fee-Raising Initiatives to Increase Pharmacist Staffing in the Absence of Direct Funding, and Drug Misadventure n a Database Analysis of Reported Medication Incidents. Abstracts from Branch Conferences 1994. “Treatment of Post-Operative Orthopaedic Pain. Individualized Medication Profiles, Australian Survey of Imported Drugs, Influenza Vaccination,” Australian Journal of Hospital Pharmacy, 25(1), pp. 102-103 (1995).

Affiliated with

Also associated with

Rating

High concentration baclofen preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High concentration baclofen preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High concentration baclofen preparations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289322